Merck’s colorectal cancer therapy fails late-stage trial
Merck faces setback as Keytruda combination trials fail to expand cancer treatment ahead of patent loss
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.